Drug Type ASO |
Synonyms- |
Target |
Action antagonists |
Mechanism TFR2 antagonists(transferrin receptor 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia in chronic kidney disease | Preclinical | United States | 14 May 2020 | |
| Anemia in chronic kidney disease | Preclinical | Italy | 14 May 2020 |





